Skip to main content
Anteris Technologies Global Corp. logo

Anteris Technologies Global Corp. — Investor Relations & Filings

Ticker · AVR ISIN · US03675P1021 ASX Manufacturing
Open in API
Filings indexed 1,664 across all filing types
Latest filing 2021-08-01 Capital/Financing Update
Country US United States of America
Listing ASX AVR

About Anteris Technologies Global Corp.

https://anteristech.com/

Anteris Technologies is a structural heart company focused on the development and commercialization of medical devices for heart valve disease. Its lead product is the DurAVR® Transcatheter Heart Valve (THV), a biomimetic valve designed for patients with severe aortic stenosis. The DurAVR® THV is engineered to mimic the performance of a healthy human aortic valve, aiming to restore normal, laminar blood flow. Clinical studies have shown the device delivers a favorable hemodynamic profile, characterized by low pressure gradients and a significant reduction in prosthesis-patient mismatch (PPM), even in patients with challenging anatomies. The company is advancing its technology through pivotal clinical trials to establish a new standard in transcatheter aortic valve replacement (TAVR) and improve long-term patient outcomes.

Recent filings

Filing Released Lang Actions
Proposed issue of securities - AVR 7 pages 33.8KB
Capital/Financing Update Classification · 100% confidence The document is an announcement from Anteris Technologies Ltd regarding a proposed issue of securities, including details about the number and type of securities, issue price, conditions, approvals, and fees related to the placement. It is structured as a formal notification to the ASX (Australian Securities Exchange) about a capital raising activity. The content focuses on the proposed issuance of shares and options, placement capacity under listing rules, and related procedural details. There are no financial statements, management discussion, or audit information present. This fits the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes.
2021-08-01 English
Notification regarding unquoted securities - AVR 9 pages 32.0KB
Share Issue/Capital Change Classification · 100% confidence The document is a notification regarding the issue of unquoted equity securities, specifically employee options, by Anteris Technologies Ltd. It details the number and type of securities issued, exercise price, expiry date, and compliance with ASX listing rules. The content focuses on the issuance of new securities under an employee incentive scheme and provides regulatory compliance information. This type of document is a formal announcement of a share issue or capital change rather than a full financial report or other filing types. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length and detail confirm it is not a brief announcement or a report publication notice but a substantive notification of capital change.
2021-08-01 English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 323.7KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Quarterly Activity Report for the Period to 30 June 2021' and includes detailed financial data such as cash flow statements, cash receipts, investing and financing activities, and commentary on the quarter's activities. It references Appendix 4C, which is a standard quarterly cash flow report for entities subject to ASX Listing Rule 4.7B. The document contains substantive financial data and analysis for a quarter, not just an announcement or summary. Therefore, it fits the definition of an Interim / Quarterly Report (IR). It is not a brief announcement, certification, or presentation, and it contains actual financial statements and commentary for the quarter ending 30 June 2021. Q2 2021
2021-07-29 English
Trading Halt 2 pages 647.9KB
Capital/Financing Update Classification · 95% confidence The document is a market announcement from Anteris Technologies Ltd regarding a trading halt requested pending an announcement about a proposed capital raising. It references ASX Listing Rule 17.1 and states the halt will remain until an announcement about the capital raising outcome or normal trading resumes. There is no financial data, report, or detailed analysis present. The document is short (2223 characters) and serves as an announcement of a trading halt related to capital raising, not the capital raising details themselves. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to financing activities and capital structure changes.
2021-07-28 English
Patent Grant 1 page 190.1KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 25 July 2021 regarding the granting of a patent for Anteris Technologies Ltd. It describes the patent details and the significance of the patent to the company's product. There is no financial data, no mention of financial results, no regulatory certifications, or meeting materials. The document is a corporate announcement about intellectual property, not a financial report or regulatory filing. It is not a report publication announcement since it does not mention any report being published or attached. The content fits best under a general regulatory announcement category that does not fit other specific categories. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2021-07-25 English
DurAVR THV Featured Prominently During TVT 2021 2 pages 175.0KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 23 July 2021 from Anteris Technologies Ltd. It discusses the company's DurAVR™ THV being featured at the TVT 2021 conference and highlights the innovation and recognition received. The content focuses on product innovation, presentations at a medical conference, and future plans for FDA submission. There are no financial statements, earnings data, management discussion of financial results, or regulatory filings related to financial performance. The document is a corporate announcement about product and innovation recognition rather than a financial report or regulatory filing. It does not fit categories like Annual Report, Earnings Release, or Interim Report. It is also not a Board/Management change, voting results, or capital update. The best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2021-07-22 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.